CHINESE HERBAL MEDICINE AND PREDNISONE INCREASE PROPORTION OF SPLENIC CD4+CD25-FOXP3+ CELLS AND ALLEVIATE GLOMERULAR LESION IN MRL/LPR MICE by Ning, Lin et al.
Ning et al., Afr J Tradit Complement Altern Med. (2015) 12(3):75-84
http://dx.doi.org/10.4314/ajtcam.v12i3.9
75
CHINESE HERBAL MEDICINE AND PREDNISONE INCREASE PROPORTION OF SPLENIC
CD4+CD25-FOXP3+ CELLS AND ALLEVIATE GLOMERULAR LESION IN MRL/LPR MICE
Lin Ning1*, Zhong Jiaxi2, Liu Ye2, Feng Jieying3, Huang Ganghua4, Sun Xia5
1Traditional Chinese Medicine Dept. of Guangdong NO.2 Provincial People’s Hospital. 2Department of Seasonal
Febrile Disease, Guangzhou University of Chinese Medicine. 3Dermatology and Venereology Dept. of Guangdong
NO.2 Provincial People’s Hospital. 4Pediatrics Dept. of The First Affiliated Hospital of Guangzhou University of
Chinese Medicine. 5Comparative Medical Laboratory of Guangdong Medical Laboratory Animal Center.
*Corresponding author: Lin Ning, Email: linning1011@sina.com
Abstract
Objective: This study investigated the effects of Chinese herbal medicine and prednisone on CD4+FoxP3+ T cells (Tregs) and Th17 cells in the
MRL/lpr mouse model of systemic lupus erythematosus.
Methods: MRL/lpr mice were treated with herbal medicine (yin-nourishing and heat-clearing therapy), prednisone, and a combination of both
for 7 weeks. The proportions of CD4+CD25+FoxP3+ cells, CD4+CD25-FoxP3+ cells, and CD4+IL-17+ cells in splenic mononuclear cell
suspension were determined by flow cytometry. Histological slices of kidneys were stained by H&E, PAS, and Masson’s method. Activity
indexes (AI) of glomerular lesions were scored.
Results: The result showed that both herbal medicine and prednisone significantly increased the proportion of CD4+CD25-FoxP3+ cells (P<0.05),
but lowered the proportion of CD4+CD25+FoxP3+ cells (P<0.05) and CD4+IL-17+ cells (P<0.05) in MRL/lpr mice. Consequently,
CD4+CD25-FoxP3+ cells became dominant CD4+ FoxP3+ cells after either treatment. AIl the glomerular lesions in both herbal medicine group
and prednisone group were significantly lower than those in the model group (P<0.05). AI was positively related with the proportion of
CD4+IL-17+ cells (Spearman's rho= 0.4958, P＜0.05), but was negatively correlated with the proportions of CD4+Foxp3+ cells(Spearman's rho=
-0.5934，P＜0.05) and CD4+CD25-FoxP3+ cells (Spearman's rho= -0.5914，P＜0.05).
Conclusion: Both Chinese herbal medicine and prednisone significantly enhanced the proportion of CD4+CD25-FoxP3+ cells and reduced the
proportion of Th17 cells in lupus-prone MRL/lpr mice. Increased proportion of CD4+CD25-FoxP3+ cells was correlated with less severe
glomerular lesions, indicating that CD4+CD25-FoxP3+ cells might play a regulatory role in the treatment of systemic lupus erythematosus.
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Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease affecting almost all organs and tissues. Most cases of SLE are mild. However,
in some severe cases, untreated lupus may progress from attack of skin and joints to internal organs including heart, lung, liver and kidney (with
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renal disease being the primary concern). Renal biopsies in patients with SLE display mesangial cell proliferation, inflammation, basement
membrane abnormalities, and immune complex deposition under light and immunofluorescence microscopes (Mok, et al., 2003). In genetically
predisposed animal models, environmental factors induce the breakdown of self-tolerance and trigger the outbreak of SLE (D'Cruz, et al., 2007,
Tsokos, 2011). However, the pathogenic mechanisms of SLE have not yet been elucidated.
Although onset of SLE affects almost every part of the immune system, it is commonly believed that altered T lymphocytes homeostasis plays
a pivotal role in the development of SLE. Regulatory T cells (Treg), a subpopulation of CD4+ lymphocytes characterized by expression of CD25
(IL-2Rα) or transcription factor FoxP3, participate in maintaining immune tolerance, and thus play a key role in suppressing the development of 
autoimmune diseases such as SLE (Buckner, 2010, Shevach, 2009). Studies have shown that SLE patients in the active phase of SLE are
characterized by a deficiency in Treg cells and an expansion of Th17 cells, suggesting that the imbalance between Th17 cells and Treg cells
might be responsible for the exacerbation of SLE (Kleczynska, et al., 2011, Yang, et al., 2009).
Therapies using immunosuppressive drugs such as corticosteroids and prednisone have been widely used in the treatment of SLE, and are
proven to improve the overall survival and severe organ damage in SLE patients. Studies have discovered that corticosteroids treatment
increases Treg cells and/or ratio of Treg cells to Th17 cells (Treg/Th17) in SLE patients (Azab, et al., 2008) (Ma, et al., 2010). However, there
are currently few reports on the effects of prednisone therapy on Treg and Th17 cells.
In addition to immunosuppressive therapies, traditional Chinese medicine (TCM) has been increasingly applied in the treatment of SLE,
among which the yin-nourishing and heat-clearing decoction is the most commonly used therapy (Hu, et al., 2002, LIANG Wei, 2005). From the
perspective of TCM, SLE can be caused by different organic damage and in general divided into heat toxin syndrome and deficiency syndromes
of Yin and Qi (Chen et al, 2011, Zhang et al, 1985). While the former typically has symptoms including fresh red skin rash, severe joint pain,
multiple oral ulcers, high fever and dark colored urine (Xu et al, 2012), the latter is mainly characterized by benign skin rash, minor joint pain,
lack of strength, shortness of breath, and small amount of urine (Li and Lu, 2012). Although formulas in treating SLE vary from each other, the
therapeutic principle of these herbal medicines is based on their abilities to replenish Qi and Yin, remove internal heat, and clear the toxin (Zhao
et al, 2012). In most cases, SLE is treated in China with corticosteroids, such as prednisone in adjunction with herbal therapies. Nevertheless, the
effects of TCM on Th17 and Treg cells have not previously been studied.
In this study, lupus-prone MRL/lpr mice were treated with herbal medicine (nourishing-yin and clearing-heat therapy), prednisone or both in
order to evaluate their efficacy in the treatment of SLE and to investigate whether the therapeutic effects of TCM and prednisone were mediated
by their regulation on Treg cells and Th17 cells in MRL/lpr mice.
Materials and Methods
Animals
Female MRL/lpr mice (8 to 10 week old) were purchased from the Animal Research Center of Nanjing University. C57BL/6 mice of similar
body weight and age were purchased from the Laboratory Animal Center of SUN Yat-sen University. The animal experiments were conducted
according to the “Principles of Laboratory Animal Care” and with the approval of our ethics committee.
Reagents
Propylene glycol monomethyl ether acetate (PMA), ionomycin and monensin were purchased from Sigma (St. Louis, MO, USA). Antibodies
were purchased from eBioscience (San Diego, CA, USA). Prednisone acetate tablets (Shanghai SINE Pharmaceutical, China) were dissolved
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into 0.5mg/mL. Chinese herbal prescription was a modified Qinghaobiejia decoction including 10 g of Artemisia apiacea, 30 g of Turtle shell,
20 g of Cornu bubali (decocted first), 10 g of Cortex Moutan, 20 g of Radix Rehmanniae, 10 g of Gentiana, and 10 g of Radix Scrophulariae,
fourteen types of agents in total. The herbal medicine were provided by Chinese herbal pharmacy of Guangdong NO. 2 Provincial People’s
Hospital, decocted by traditional method, and concentrated into a solution of 1.1g (content of crude drug) /mL.
Treatment of animals
The MRL/lpr mice were randomly divided into the following four groups with 8 mice in each group: model group, TCM group, prednisone
group, and combination group. Another group of 8 C57BL/6 mice was used as control. Mice in the herbal medicine group were given
concentrated TCM solution (17.5ml/kg/d). The prednisone group was given solution of prednisone acetate (8.75mg/kg/d). The combination
group was given both herbal medicine and prednisone acetate of same dosage as the single-therapy groups. The model group and the control
group were given normal saline of the equal volume. All the medicines and saline were administrated intragastrically. The treatment lasted seven
weeks. The mice were executed on the 50th day after treatment.
Preparation of splenic mononuclear cells (SMCs)
Spleens obtained from executed animals were immediately grounded. Mononuclear cells were isolated by filtration using a wire mesh strainer,
collected by centrifugation, and resuspended in RPMI1640 culture medium at 3×10 9cells/L.
Identification of Treg and Th17 cells by flow cytometry
In order to detect Treg cells, SMCs were stained with anti-mouse CD4 FITC, anti-mouse CD25 APC, and anti-mouse/rat FoxP3 PE according
to the manufacturer’s protocol, and analyzed by a FACSCalibur system (BD Biosciences, San Jose, CA, USA) on the same day of cell isolation.
In order to detect Th17 cells, SMCs were pre-incubated in 50 ng/mL PMA and 50 μg/mL ionomycin in a tissue culture incubator at 37°C for 1 
h, followed by incubation in 0.1 mg/mL monensin in a 5% CO2 incubator at 37°C for 4 h. Incubated cells were stained with anti-mouse/rat
IL-17a PE and anti-mouse CD4 FITC, and analyzed by a FACSCalibur system.
Pathological assessment of kidneys
Perfusion-fixed tissue blocks from mouse kidneys were embedded in paraffin and sliced into 2 μm sections. Slices were stained with H&E, 
PAS and Masson’s methods, respectively, and subjected to microscopic examination using Olympus BX41. Images were analyzed with an image
analysis system (Image-Pro Express 5.1.1.14) in a blinded manner. Activity indexes (AI) of glomerular lesions were determined based on a
previously reported method (Austin III, et al., 1983). Twenty glomeruli from each mouse were examined.
Statistical analysis
Statistical analysis was performed using Stata 11.0. Proportion of subpopulations was arcsine transformed. Differences among groups were
analyzed by ANOVA and Scheffe tests (with homogeneous variance), or by Kruskal–Wallis and Nemenyi tests (with heterogeneous variance).
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Correlation between AI and proportion of T cell subpopulations was analyzed by Spearman rank correlation. P value less than 0.05 was
considered significant.
Results
Proportions of Treg cell and Th17 cell
The proportion of CD4+CD25+FoxP3+ or CD4+CD25-FoxP3+ cells in the model group was not significantly different from that in the control
group (P>0.05). The proportion of CD4+CD25+FoxP3+ cells in TCM and prednisone groups was significantly lower compared with the model
group (P<0.05), whereas the proportion of CD4+CD25-FoxP3+ cells in both groups was significantly higher (P<0.05), indicating similar effects
of both therapies on the proportion of Treg cells. However, the proportion of Treg cells in the combined therapy group was not significantly
different from that in the model group (P>0.05). The proportion of CD4+CD25-FoxP3+ cells in all 3 treatment groups was significantly higher
than the proportion of CD4+CD25+FoxP3+ cells, resulting in CD4+CD25-FoxP3+-dominant after the treatment (See Table 1 and Figure 1).
The proportion of CD4+IL-17+ cells in the model group was significantly higher than that in the control group (P<0.05). The proportion of
CD4+IL-17+ cells in all 3 treatment groups was significantly lower compared with the model group (P<0.05).
Table 1: The proportion of three subpoplutions of T cells in different groups
Groups CD25+FoxP3+/
CD4+(%)
CD25-FoxP3+/CD4
+(%)
IL-17+/CD4+
(%)
IL-17+/FoxP3+
(%)
Control group (2.65±0.08) (3.78±0.74) (4.55±0.28)* 72±12.62
Model group (4.38±0.27) (1.73±0.48) (5.6±0.18) 92.91±12.84
Herbal medicine group (1.62±0.22)* (12.43±0.59)* (4.51±0.22)*# 32.16±1.28*#⊕
Prednisone group (1.54±0.08)* (10.05±0.16)* (4.96±0.12)* 42.78±1.06*
Combination group (2.51±0.21) (5.46±0.32) (4.72±0.12)* 59.27±2.92*
Original ratio of subpopulation was arcsine-square-root transformed.
*, P<0.05 when compared with the model group; #, P<0.05 when compared with prednisone group; and ⊕, P<0.05 when compared with the
combination group.
Figure1: The proportions of CD25+FoxP3+ /CD4+ and CD25-FoxP3+ /CD4+ in different groups
*, indicates P<0.05 when compared with the model group.
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AI of glomerular lesions
As shown in Figure 2, the glomerular lesions in MRL/lpr mice in all three treatment groups were significantly ameliorated compared with
the model group as demonstrated by pathological assessment of kidneys by H&E, PAS and Masson’s staining. Furthermore, AIs of glomerular
lesions in all three treatment groups were significantly lower than that in the model group (P<0.05) (See Table2).
Figure 2: Pathological analysis of glomerular lesions in all groups by H&E, PAS and Masson’s staining. a, H&E staining (X400), b, Masson
staining (X400), and c, PAS staining (X400). Glomerular lesions are marked by black arrows.
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Table 2：AIs of glomerular lesions in different groups
AI of glomerular lesions
Model group 9.75±1.49
Herbal medicine group 3.50±0.53*
Prednisone group 3.38±1.19*
Combination group 4.00±1.41*
Notes: *P<0.05, compared with Model group
Correlation between AI of glomerular lesions and the proportion of T cell subpopulations
Results of Spearman rank correlation (Table 3) showed that the ratio of CD25-FoxP3+/CD4+cells (Spearman’s rho=-0.5914, P<0.05) and
CD4+FoxP3+ cells (Spearman’s rho=-0.5934, P<0.05) were negatively correlated with AIs of glomerular lesions, whereas the ratio of Th17 cells
was positively correlated with AIs in MRL/lpr mice (Spearman’s rho=-0.4958, P<0.05).
Table 3:. Correlation between the ratio of T cell subpopoulations and AI of glomerular lesions
Ratio of subpopulation No. of mouse with different AI levels Total
number
0-4 5-8 9-12
CD4+FoxP3+a
4.80%-7.80% 0 4 6 10
7.81%-11.69% 10 1 0 11
11.70%-15.0% 10 1 0 11
CD4+CD25-FoxP3+b
0%-5.00% 0 3 6 9
5.01%-10.00% 9 2 0 11
10.01%-13.22% 11 1 0 12
Th17c
4.10%-4.70% 8 2 0 10
4.71%-5.10% 11 2 0 13
5.11%-5.91% 1 2 6 9
a: Spearman's rho= -0.5934, P=0.0002
b: Spearman's rho= -0.5914, P=0.0002
c: Spearman's rho= 0.4958, P=0.0029
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Discussion
In this study, we found that the glomerular lesions in MRL/lpr mice in all three treatment groups were significantly ameliorated compared
with the model group as revealed by the histological study of the kidneys. Furthermore, AIs of glomerular lesions in all three treatment groups
were significantly lower than that in the model group, suggesting that both the yin-nourishing and heat-clearing therapy, and prednisone were
effective in the treatment of SLE. These results were consistent with previous literature which suggested that Chinese herbs alone could function
reasonably well as a treatment for lupus (Fan et al. 1999, Wen 2001). However, we also found that there was no significantly difference in AIs of
glomerular lesions between the combined group and the herbal medicine or prednisone group, suggesting that the combined therapy was not
superior to either therapy. The results were contrary to previous findings that Chinese medicine appears to be suitable as an adjunct to modern
medical therapies (Wu et al, 1998, Zhong et al, 1999) and herbal medicine has substantially reduced the dosage of corticosteroids needed for an
effective treatment in SLE patients (Zhong et al., 2013). The inconsistence might be caused by different response to the combination therapy in
MRL/lpr lupus mice. Furthermore, the combination therapy might offer potential clinical advantages such as the improvement of the overall
physical condition and long-term quality of life of SLE patients even although it could not significantly change one or more laboratory indicators
of the disease.
In studies of SLE related immune disorders, it has been confirmed that CD4+CD25+FoxP3+ cells (Tregs) suppress humoral autoimmunity
primarily by direct inhibition of autoreactive B cells (Iikuni, et al., 2009). Intervention such as corticosteroids treatment increases the proportion
of Treg cells or the Treg/Th17 ratio in SLE patients (Ma, et al., 2010). As the key player of peripheral immune tolerance, Tregs frequently
indicate impaired functions in SLE patients (Xing, et al., 2012a), accompanied by an increase of Th17 (Xing, et al., 2012b). The
CD4+CD25-FoxP3+ subpopulation have been recently found to be associated with the progression of SLE. The number of these cells increases in
new-onset SLE patients. CD4+CD25-FoxP3+ is a potential precursor of functional Tregs. Studies concerning characteristics of subpopulation of
Tregs indicated that expression of Foxp3 converts naïve CD4+CD25- T cells to phenotypical and functional Treg cells (Hori, et al., 2003). This is
supported by a study of Bing Yan et.al, which suggests that CD4+CD25-FoxP3+ is potential reservoir of CD4+CD25+FoxP3+ cells (Yan, et al.,
2009). Furthermore, it is reported that most CD4+CD25-FoxP3+ cells in SLE patients expression memory CD4+ T cells marker, CD45RO,
indicating that CD4+CD25-FoxP3+ cells may be the origin of adaptive CD4+CD25+FoxP3+ cells(Walker, et al., 2005). Some scientists believe
that the increase of CD4+CD25-FoxP3+ cells serves as compensation for loss of CD4+CD25+FoxP3+ cells (Suen, et al., 2012). On the other hand,
blocking of CD25 with Basiliximab, an anti-CD25 monoclonal antibody, did not change the proportion of FoxP3+ cells among CD4 T cells (de
Herve, et al., 2010). Obviously, the alteration in T cell subpopulations remains controversy. Moreover, the clinical significance of their alteration
in SLE patients is largely unclarified. In this study, we found that the percentages of CD4+CD25+FoxP3+ cells (Treg cells) in the model group
were higher than that in the control group, and were down-regulated by herbal medicine or prednisone therapy. Furthermore, a slightly decreased
proportion of CD4+CD25-FoxP3+ cells was observed in the model group compared with the control group, and was substantially up-regulated
after either treatment. Consequently, CD4+CD25-FoxP3+ cells became dominant CD4+ FoxP3+ cells after either treatment. We also found that
the percentage of Th17 cells in the model group was higher compared with the control group, and was significantly reduced by either
intervention. Based on the aforementioned evidences, we proposed that CD4+CD25-FoxP3+ to some extent exerted similar suppressive effect on
SLE as that reported in other studies described above, and the increase in the proportion of CD4+CD25-FoxP3+ after intervention is either a
potential prelude of functional SLE suppressor Tregs, or a subset of functional Tregs itself.
Our study has several limitations. First, it examined only one dosage of herbal medicine, whereas three dosages (low, moderate and high
dosages) are generally included in other studies (Zhong et al., 2013). Future comprehensive studies will be needed including different dosages of
herbal medicine as well as dosages of both herbal medicine and prednisone. Second, our study revealed the therapeutic effect of both the herbal
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medicine and prednisone, but did not compare the side effects of them. Prednisone has been previously found to cause a variety of side effects,
such as musculoskeletal complications like avascular necrosis and Cushinoid symptoms (Petri, 1995), whereas Chinese herbal medicine has been
considered to be a more safe and effective treatment compared to prednisone (Zhong et al., 2013).
In summary, the herbal medicine (nourishing-yin and clearing-heat therapy) and prednisone alone or in combination were effective in the
treatment of SLE by significantly ameliorating glomerular lesions in SLE mice. We also found that both Chinese herbal medicine
(nourishing-yin and clearing-heat therapy) and prednisone could effectively enhance the proportion of CD4+CD25-FoxP3+ cells and reduce the
proportion of Th17 cells in lupus-prone MRL/lpr mice. AI of glomerular lesions was positively correlated with the proportion of Th17 cells, but
negatively correlated with the proportion of CD4+CD25-FoxP3+ cells. Neither herbal medicine nor prednisone promoted proliferation of
CD4+CD25+FoxP3+ cells in these mice. We suspected that CD4+CD25-FoxP3+ cells are potential precursors of functional CD4+CD25+FoxP3+
cells. However, dynamic simultaneous sampling of SMCs and peripheral blood mononuclear cells (PBMC) will be needed to validate our
suspicion. It is also worth noting that the combined therapy was not as effective as individual therapies. The underlying mechanism requires
further studies.
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